Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Siplizumab in plaque psoriasis
NCT00192452Phase 2Completed
- Sponsor
- MedImmune
- Start
- Mar 2001
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of siplizumab in plaque psoriasis, sponsored by MedImmune. Started Mar 2001; status: completed.
02
Drugs
siplizumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00192452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00192452.